# EDGAR Filing Document

**Accession Number:** 0001109486
**File Stem:** 0001493152-23-005159
**Filing Date:** 2023-2
**Character Count:** 7768
**Document Hash:** 6db076aa1f97cdbb815a09317ac1c7ac
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-005159.hdr.sgml**: 20230215

**ACCESSION NUMBER**: 0001493152-23-005159

**CONFORMED SUBMISSION TYPE**: NT 10-Q

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230215

**DATE AS OF CHANGE**: 20230215

**EFFECTIVENESS DATE**: 20230215

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Endexx Corp
- **CENTRAL INDEX KEY:** 0001109486
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **IRS NUMBER:** 860577075
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** NT 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-30233
- **FILM NUMBER:** 23634454

**BUSINESS ADDRESS:**
- **STREET 1:** 38246 NORTH HAZELWOOD CIRCLE
- **CITY:** CAVE CREEK
- **STATE:** AZ
- **ZIP:** 85331
- **BUSINESS PHONE:** (480) 595-6900

**MAIL ADDRESS:**
- **STREET 1:** 38246 NORTH HAZELWOOD CIRCLE
- **STREET 2:** CAVE CREEK
- **CITY:** CAVE CREEK
- **STATE:** AZ
- **ZIP:** 85331

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PANAMED CORP
- **DATE OF NAME CHANGE:** 20020329

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MICRON SOLUTIONS INC
- **DATE OF NAME CHANGE:** 20000317

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

---

| |
|:---|
| SEC FILE NUMBER |
| 0-11734 |
| CUSIP NUMBER |
| 29259K 10 2 |

---

**FORM 12b-25**

**NOTIFICATION OF LATE FILING**

*(Check one):* ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR <br> ☐ Form N-CSR

For Period Ended: <u>December 31, 2022</u>

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

For the Transition Period Ended:  

*Read Instructions (on back page) Before Preparing Form. Please Print or Type.*

**Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.**

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

**PART I — REGISTRANT INFORMATION**

**ENDEXX CORPORATION**

Full Name of Registrant

Former Name if Applicable

**38246 North Hazelwood Circle**

Address of Principal Executive Office *(Street and Number)*

 

**Cave Creek, Arizona 85331**

City, State and Zip Code

**PART II — RULES 12b-25(b) AND (c)**

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense

**☒** (b) The
 subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion
 thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report
 or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the
 fifth calendar day following the prescribed due date; and

(c) The
 accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

**PART III — NARRATIVE**

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Endexx Corporation (the "Company") has determined it is unable to file its Quarterly Report on Form 10-Q timely for the fiscal period ended December 31, 2022 (the "Form 10-Q") due to the timing of concluding the final internal accounting and external audit work for its fiscal year ended September 30, 2022, and the related XBRL coding for that 10-K. The primary reason for the continued delay in completing and filing its Annual Report and the cascading delay in finalizing its accounting and preparing the related MD&A for its Quarterly Report has been COVID. Each of the Company's employees and substantially all of its primary consultants were infected by the novel coronavirus in the months preceding the date of this Notification of Late Filing, some of which infections were serious enough to require multiple-day hospital stays.

Nevertheless, in accordance with Rule 12b-25 of the Securities Exchange Act of 1934, the Company currently intends to file its Form 10-Q no later than the fifth calendar day following the prescribed due date.

*Cautionary Note to Investors Regarding Forward Looking Statements*

 

This Notification of Late Filing on Form 12b-25 contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements include, among other things, the statement that the Company expects to file its Form 10-Q no later than the fifth calendar day following the prescribed due date. Notwithstanding the Company's best efforts, there can be no assurance that the Company will be able to file its Form 10-Q within that time period. Forward-looking statements are subject to a number of uncertainties and risks, including the Company's ability to complete items necessary to file the Form 10-Q within the anticipated timeframe. Such forward-looking statements are made only as of the date of this Notification of Late Filing on Form 12b-25, and the Company does not undertake any obligation to update any forward-looking statement to reflect subsequent events or circumstances, except to the extent required by law.

**PART IV — OTHER INFORMATION**

(1) Name
 and telephone number of person to contact in regard to this notification

---

| | | |
|:---|:---|:---|
| **Todd Davis, President and Chief Executive Officer** | **(480)** | **595-6900** |
| (Name) | (Area Code) | (Telephone Number) |

---

(2) Have
 all other periodic reports required under Section 13 or 15(d) of the Securities Exchange
 Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months
 or for such shorter period that the registrant was required to file such report(s) been filed?
 If answer is no, identify report(s).

☐ Yes ☒ No <br>Annual Report on Form 10-K for the fiscal year ended September 30, 2022.

(3) Is
 it anticipated that any significant change in results of operations from the corresponding
 period for the last fiscal year will be reflected by the earnings statements to be included
 in the subject report or portion thereof?

☐ Yes ☒ No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

**ENDEXX CORPORATION**

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| Date | February 15, 2023 | By | ***/s/*** *Todd Davis* |
|  |  |  | Todd Davis, President and Chief Executive Officer |

---

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.

**ATTENTION**

**Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).**